- Joined
- Jul 16, 2008
- Messages
- 21,845
- Points
- 113
"The drugmaker said in a statement on Friday that it was no longer taking new patients in a clinical trial of the treatment “due to the overwhelming efficacy” and planned to submit the findings to U.S. regulatory authorities for emergency authorization as soon as possible. Pfizer shares gained 11% as of 6:52 a.m. in New York. "
https://www.bloomberg.com/news/arti...k-u-s-nod-for-covid-pill-after-strong-results
https://www.bloomberg.com/news/arti...k-u-s-nod-for-covid-pill-after-strong-results